Home › Trial NCT05951777
Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury
- Trial IDNCT05951777
- StatusRecruiting
- PhasePhase 2
- Study typeInterventional
- SponsorHope Biosciences LLC
- Enrollment51
- Start date2024-04-16
- ConditionsTraumatic Brain Injury
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.